Evidence map›Paper›PMID 29531042›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Requirement for intron structures in activating the

Hisashi Wada, Nighat Yasmin, Kiyokazu Kakugawa, Michiko Ohno-Oishi, Sebastian Nieke, Chizuko Miyamoto, Sawako Muroi, Ichiro Taniuchi

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Differential Requirement ofFrontiers in immunology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hisashi WadaLaboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences, 230-0045 Yokohama, Japan.
Nighat YasminLaboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences, 230-0045 Yokohama, Japan.
Kiyokazu KakugawaLaboratory for Immune Crosstalk, RIKEN Center for Integrative Medical Sciences, 230-0045 Yokohama, Japan.
Michiko Ohno-OishiLaboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences, 230-0045 Yokohama, Japan.
Sebastian NiekeLaboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences, 230-0045 Yokohama, Japan.
Chizuko MiyamotoLaboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences, 230-0045 Yokohama, Japan.
Sawako MuroiLaboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences, 230-0045 Yokohama, Japan.
Ichiro TaniuchiLaboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences, 230-0045 Yokohama, Japan; ichiro.taniuchi@riken.jp.ORCID 0000-0002-9853-9068
RIKEN Center for Integrative Medical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During differentiation of CD4

Indexed as

IntronsAnimalsCD4 AntigensCD4-Positive T-LymphocytesCD8 AntigensCD8-Positive T-LymphocytesCell DifferentiationCells, CulturedMiceRNA SplicingThymocytesT-Lymphocytes, CytotoxicCD4 AntigensCD8 antigen, alpha chainCD8 AntigensCd8 geneDNA methylationintron-mediated enhancementT cell development

Identifiers

PMID29531042
PMCPMC5879687
OpenAlexW2793499665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.